Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Delayed Price · USD
5.22
-0.51 (-8.90%)
At close: May 18, 2022 4:00 PM
5.26
0.04 (0.77%)
Pre-market:May 19, 2022 7:40 AM EDT
Market Cap1.17B
Revenue (ttm)134.69M
Net Income (ttm)-175.29M
Shares Out224.38M
EPS (ttm)-0.89
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,907,692
Open5.53
Previous Close5.73
Day's Range5.16 - 5.75
52-Week Range4.51 - 36.36
Beta1.26
AnalystsBuy
Price Target17.95 (+243.9%)
Earnings DateMay 4, 2022

About PACB

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonuclease...

IndustryLife Sciences Tools & Services
IPO DateOct 27, 2010
Employees728
Stock ExchangeNASDAQ
Ticker SymbolPACB
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for PACB stock is "Buy." The 12-month stock price forecast is 17.95, which is an increase of 243.87% from the latest price.

Price Target
$17.95
(243.87% upside)
Analyst Consensus: Buy
Stock Forecasts

News

PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows

Advanced Automation Aims to Optimize Service Lab Efficiency and Highly Reproducible Data Production from HiFi Long-Read Sequencing Advanced Automation Aims to Optimize Service Lab Efficiency and Highly ...

1 week ago - GlobeNewsWire

PacBio to Participate in the BofA Securities 2022 Healthcare Conference

MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada.

1 week ago - GlobeNewsWire

PacBio's (PACB) Q1 Earnings Miss Estimates, Revenues Beat

PacBio (PACB) sees strength in Q1 segmental revenues, led by robust consumable and instrument sales.

1 week ago - Zacks Investment Research

Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of -15.63% and 1.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

PacBio Announces First Quarter 2022 Financial Results

MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022.

2 weeks ago - GlobeNewsWire

Pacific Biosciences of California (PACB) Expected to Beat Earnings Estimates: Should You Buy?

Pacific Biosciences (PACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago - Zacks Investment Research

PacBio and Children's Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease

MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research collaboration...

3 weeks ago - GlobeNewsWire

PacBio transforms access to the epigenome and streamlines workflows

Significant enhancements to the Sequel II/IIe platform include methylation calling in native DNA, greatly accelerated sample preparation, and support for gene therapy applications Significant enhancemen...

3 weeks ago - GlobeNewsWire

PacBio to Report First Quarter 2022 Financial Results on May 4, 2022

MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2022 financial results on Wednes...

4 weeks ago - GlobeNewsWire

3 Things About Pacific Biosciences of California That Smart Investors Know

Anyone thinking about buying shares should know them, too.

1 month ago - The Motley Fool

PacBio Enters Agricultural Industry Collaboration with Corteva Agriscience to Develop High-Throughput Plant, Pest and...

The companies will leverage high-throughput whole genome HiFi sequencing for advanced plant biotechnology, breeding and crop protection product development The companies will leverage high-throughput wh...

1 month ago - GlobeNewsWire

HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of ...

Science magazine publication details how the human genome was finally completed with the help of PacBio long-read technology Science magazine publication details how the human genome was finally complet...

1 month ago - GlobeNewsWire

PacBio Opens European Headquarters in London

Company Announces New European Headquarters to Serve Growing Customer Demand in Europe, Middle East and Africa Region

1 month ago - GlobeNewsWire

Why Is Pacific Biosciences (PACB) Down 13.6% Since Last Earnings Report?

Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

PacBio (PACB) Supports SickKids With Sequencing Technology

PacBio (PACB) to help SickKids in detecting potential genetic causes of a range of medical and developmental conditions.

2 months ago - Zacks Investment Research

PacBio Supports SickKids to Investigate Use of HiFi Sequencing in Undiagnosed Genetic Conditions

SickKids will use HiFi Sequencing to explore potential genetic causes of a range of medical and developmental conditions SickKids will use HiFi Sequencing to explore potential genetic causes of a range ...

2 months ago - GlobeNewsWire

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of ...

2 months ago - GlobeNewsWire

PacBio Welcomes Dr. Michael Eberle as Vice President of Computational Biology

Genomics Industry Veteran to Oversee Development of Robust Computational Biology Program Genomics Industry Veteran to Oversee Development of Robust Computational Biology Program

2 months ago - GlobeNewsWire

PacBio's (PACB) Q4 Earnings Miss Estimates, Revenues Top

PacBio (PACB) sees strength in Q4 segmental revenues, led by robust consumable and instrument sales.

3 months ago - Zacks Investment Research

KK Women's and Children's Hospital and PacBio Collaborate in Asia's First Study of Unexplained Neurodevelopmental Dis...

PacBio HiFi Sequencing Technology Will Be Used to Investigate Effect on Diagnostic Yield of Unresolved Rare Diseases in Children PacBio HiFi Sequencing Technology Will Be Used to Investigate Effect on D...

3 months ago - GlobeNewsWire

Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of -7.14% and 0.05%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results

MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021.

3 months ago - GlobeNewsWire

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking virtually at the following investor conferences:

3 months ago - GlobeNewsWire

Analysts Estimate Pacific Biosciences of California (PACB) to Report a Decline in Earnings: What to Look Out for

Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

PacBio to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022

MENLO PARK, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial res...

3 months ago - GlobeNewsWire